NCT06035601

EHR-integrated rUTI Texting Platform

An EHR-integrated Texting Platform to Promote Self-management in Women With Recurrent Urinary Tract Infections

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 104 (actual)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: Female
• Age: 18 Years – 100 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care? Participants enrolled onto the texting platform will: • receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.

Conditions

• Recurrent Urinary Tract Infection

Interventions

Type	Name	Description
DEVICE	EHR-integrated texting platform (Urotrust)	* An evidence-based algorithm that provides symptom triage and clinical guidance during an episode of acute UTI * Evidence-based prevention education material on recurrent UTIs * 5 standing orders for urinalysis and urine culture in the EHR upon enrollment * Standard-of-care management for recurrent UTI
OTHER	Usual care	• Standard-of-care management of recurrent UTI (phone calls and/or secure EHR messages for acute symptoms) and follow up visits as determined by patients and their providers.

Timeline

• Start date: 2024-03-07
• Primary completion: 2025-05-31
• Completion: 2025-05-31
• First posted: 2023-09-13
• Last updated: 2025-08-17

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study